✦ LIBER ✦

Influence of length of time to diagnosis and treatment on the survival of children with acute lymphoblastic leukemia: A population-based study

✍ Scribed by Baker, Jillian M.; To, Teresa; Beyene, Joseph; Zagorski, Brandon; Greenberg, Mark L.; Sung, Lillian

Book ID: 125469743
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 511 KB
Volume: 38
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2013.11.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Time Trends in the Incidence of Acute Ly

Time Trends in the Incidence of Acute Lymphoblastic Leukemia among Children 1976-2002: A Population-Based Nordic Study

✍ Anne Louise Svendsen; Maria Feychting; Lars Klæboe; Frøydis Langmark; Joachim Sc 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Induction death and treatment-related mo

Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Münster study group

✍ Prucker, C; Attarbaschi, A; Peters, C; Dworzak, M N; Pötschger, U; Urban, C; Fin 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 127 KB

Incidence of childhood acute lymphoblast

Incidence of childhood acute lymphoblastic leukemia (ALL) and population-based treatment results in Switzerland: Experiences with 507 study and 149 nonstudy patients

✍ Stupnicki, A. ;von der Weid, N. ;Imbach, P. ;Arnet, B. ;Berchtold, W. ;Delaleu, 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB

## Abstract Of 656 patients with ALL (all types) diagnosed in Switzerland during 4 consecutive 4‐year periods (1976–1979, 1980–1983, 1984–1987, 1988–1991), 507 were officially registered on protocols (“study” patients) while 149 were not (“nonstudy” patients). The mean incidence of 3.8/100,000 chil

Outcome after first relapse in children

Outcome after first relapse in children with acute lymphoblastic leukemia: A population-based study of 315 patients from the nordic society of pediatric hematology and oncology (NOPHO)

✍ Schroeder, H. ;Garwicz, S. ;Kristinsson, J. ;Siimes, M. A. ;Wesenberg, F. ;Gusta 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

## Abstract This study reports the outcome after relapse of acute lymphoblastic leukemia (ALL) in a population‐based study of 809 children over 1 year of age diagnosed July 1981 through June 1986 and with non‐B acute lymphoblastic leukemia in the five Nordic countries. By January 1994, 315 children

Study of the pharmacokinetic and pharmac

Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia

✍ Noha M. EL-Khodary, Sahar M. EL-Haggar, Manal A. Eid, Emad N. Ebeid 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 301 KB

The low frequency of defective TPMT alle

The low frequency of defective TPMT alleles in Turkish population: A study on pediatric patients with acute lymphoblastic leukemia

✍ Tugba Boyunegmez Tumer; Gulen Ulusoy; Orhan Adali; Gurses Sahin; Sevgi Gozdasogl 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract 6‐Mercaptopurine (6MP) is an essential anticancer drug used in the treatment of childhood acute lymphoblastic leukemia (ALL). Thiopurine methyltransferase (TPMT) polymorphisms are the major determinants of interindividual differences in the severe toxicity or efficacy of 6MP. Four varia